Chemoinformaics analysis of BUTYLIDENE-PHTHALIDE
| Molecular Weight | 188.226 | nRot | 2 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 12 |
| Exact Molecular Weight | 188.084 | nRing | 2 |
| Solubility: LogS | -3.333 | nHRing | 1 |
| Solubility: LogP | 3.273 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 29.6455 |
| nHD | 0 | BPOL | 14.6425 |
| QED | 0.667 |
| Synth | 2.45 |
| Natural Product Likeliness | 1.471 |
| NR-PPAR-gamma | 0.073 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.744 |
| Pgp-sub | 0.011 |
| HIA | 0.003 |
| CACO-2 | -4.588 |
| MDCK | 0.0000308 |
| BBB | 0.169 |
| PPB | 0.940088 |
| VDSS | 1.066 |
| FU | 0.036508 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.335 |
| CYP2c19-inh | 0.856 |
| CYP2c19-sub | 0.068 |
| CYP2c9-inh | 0.545 |
| CYP2c9-sub | 0.828 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.237 |
| CYP3a4-inh | 0.061 |
| CYP3a4-sub | 0.133 |
| CL | 8.316 |
| T12 | 0.695 |
| hERG | 0.033 |
| Ames | 0.009 |
| ROA | 0.09 |
| SkinSen | 0.932 |
| Carcinogencity | 0.127 |
| EI | 0.987 |
| Respiratory | 0.445 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.629457 |